4 articles
Millions of Americans using GLP-1 weight-loss drugs are leading to significant changes in clothing purchases. This trend could inject up to $13 billion into the apparel industry annually as consumers buy new wardrobes to fit smaller sizes. Retailers are hopeful for a major sales boost, though drug costs may impact consumer spending.
Tom Brady has joined health tech firm eMed as Chief Wellness Officer, coinciding with the company's $200 million funding round and $2 billion valuation. eMed utilizes AI and GLP-1 medications to help employers manage healthcare costs and improve employee health. The company aims to provide a disciplined, supportive program for individuals seeking to improve their well-being.
Vanda Pharmaceuticals has secured a historic FDA evidentiary hearing for its jet lag disorder treatment, the first in 45 years. The company also recently gained FDA approval for a therapy that significantly reduces nausea and vomiting associated with popular GLP-1 weight-loss drugs.
Explore how to naturally activate your body's weight loss system by supporting the GLP-1 hormone. Learn dietary and lifestyle strategies to promote fat loss, preserve muscle, and improve metabolic health without relying on medication.
